Insider trading is back in the headlines, with 30 employees from prominent law firms accused of exploiting confidential information from over 30 M&A deals in a scheme that spanned decades. They netted millions.

It’s a reminder that life science companies are particularly vulnerable to the risk of insider trading. From clinical trial results and FDA decisions, to partnership announcements and M&A activity, employees often have access to material nonpublic information (MNPI) long before the market does.

Unfortunately, many employees do not fully understand that trading during sensitive periods or sharing inside information with family or friends can trigger significant legal and reputational consequences.

Effective insider trading compliance requires more than a policy document. Life science employees need practical, scenario-based training that helps them recognize risky situations before they become enforcement issues. That is why we recommend targeted insider trading training tailored to the realities of our industry.

Our off-the-shelf Insider Trading module can help your company educate employees on identifying MNPI, understanding trading restrictions, recognizing tipping risks, and promoting a stronger culture of compliance – all through scenarios relevant to life sciences employees.

Care to see it? Reply to this email or reach out to compliance@nxlevelsolutions.com. We’ll be happy to provide you access and discuss whether this module might be an important addition to your compliance training program.

Thanks for reading!

-NXLevel Compliance

P.S. Insider Trading is just one of the life sciences-specific training modules in our Compliance Foundations Library. For a complete list, visit our website.